I am a UCLA-trained, triple board-certified physician (American Board of Psychiatry and Neurology, American Board of Addiction Medicine, American Board of Anti-Aging & Regenerative Medicine).
I am also the president of “Uplyft Longevity Center” in Los Angeles, California, where I specialize in stem cell therapy, ketamine therapy, as well as a wide range of therapeutics to enhance patients’ overall health and combat diseases in a holistic manner, by enhancing the body’s innate regenerative potential.
I believe in advancing the field of stem cell therapy through education of both physicians and the public, and founded American Academy of Integrative Cell Therapy, where I provide training to physicians on the science, clinical evidence and safe protocols in Stem Cell Therapy.
I am a proponent of high quality clinical research, and have originated a traumatic brain injury (TBI) study, and I am a published author in scientific journals. In an attempt to provide patients and other clinicians with the highest quality stem cell products, I founded Chara Biologics, where I developed a potent and comprehensive stem cell product CharaCore with a patent-pending formulation, as well as an all-natural stem cell skin cream CharaOmni.
I was recognized for my contribution to the field of regenerative medicine and awarded the “Top Doctor of the Year in Stem Cell Therapy” in 2019 and “Stem Cell Doctor of the Decade” in 2021 by IAOTP (International Association of Top Professionals). My memoir Tiger of Beijing has garnered tremendous interest, and was named “2020 Book of the Year” from IAOTP and showcased at Time Square.
Dr. Kong is a member of American Academy of Anti-Aging Medicine, certified in advanced cellulartherapeutic protocols, is board-certified by American Board of Psychiatry and Neurology, and American Boardof Addiction Medicine.
Dr. Kong is the founder of Chara Biologics, a company that provides premier regenerative medicine products to physicians across the United States. She is also the president of American Academy of Integrative Cell Therapy, and an avid educator, helping physicians to become fully trained in the science and practice of regenerative medicine.
Dr. Kong is also keenly interested in clinical research to advance the field of regenerative medicine, and has spearheaded a clinical study on the effect of stem cell therapy for traumatic brain injury (TBI).